Investor profile
4BIO Capital has backed 4 European tech companies across 5 funding rounds between 2020 and 2026, joining rounds totalling €206M. Most active in Healthtech. Data as of 9 Oct 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Sparingvision | France | 2 | €120M |
| Aptadir Therapeutics | Italy | 1 | €40M |
| Araris Biotech | Switzerland | 1 | €24M |
| ViaNautis | UK | 1 | €23M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Sparingvision | Series B | €75M | 2022-09 |
| Sparingvision | Other | €45M | 2020-10 |
| Araris Biotech | Other | €24M | 2022-10 |
| ViaNautis |
| Series A |
| €23M |
| 2023-11 |
